This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 2Chuck, Anderson
- 1Akpinar, Ilke
- 1Chojecki, Dagmara
- 1Collins, Seana
- 1Corabian, Paula
- 1El Shayeb, Mohamed
-
Cost Estimation of Point of Care B-Type Natriuretic Peptide for the Diagnosis of Heart Failure in the Emergency Department - Application to Alberta
Download2005-05-30
Chuck, Anderson, Collins, Seana, Jacobs, Philip
The aim of this report is to provide a cost estimate, over a one year time period from a payer’s perspective, of Biosite Triage Point-of-Care (POC) B-Type Natriuretic Peptide (BNP) assay used to rule out congestive heart failure (CHF) from other pulmonary conditions for patients presenting in...
-
Newborn blood spot screening for galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency
Download2016-03-23
Waye, Arianna, El Shayeb, Mohamed, Guo, Bing, Chuck, Anderson, Akpinar, Ilke, Chojecki, Dagmara, Yan, Charles, Corabian, Paula
This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle...